, Tracking Stock Market Picks
Enter Symbol:
Autodesk, Inc. (ADSK) [hlAlert]

down 2.95 %

Autodesk, Inc. (ADSK) upgraded to Overweight by JP Morgan

Posted on: Thursday,  Jan 30, 2014  8:25 AM ET by JP Morgan

JP Morgan rated Overweight Autodesk, Inc. (NASDAQ: ADSK) on 01/30/2014, when the stock price was $51.52. Since
then, Autodesk, Inc. has lost 2.95% as of 11/20/2015's recent price of $50.00.
If you would have followed this JP Morgan's recommendation on ADSK, you would have lost 2.95% of your investment in 659 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

JPMorgan is a leading financial services firm with one of the largest client franchises in the world. We partner with our clients to offer the most complete and innovative solutions in the industry to help them achieve their goals. For more than 200 years, we have taken a long-term approach to our clients and to the way we conduct business. Our firm has grown considerably in scale and scope, but our commitment to our core principle of doing "only first-class business... in a first-class way" has never been stronger.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/30/2014 8:25 AM Buy
as of 10/17/2014
1 Week down  -5.45 %
1 Month down  -7.46 %
3 Months down  -8.35 %
1 YTD down  -1.41 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/24/2012 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy